Facial Rejuvenation Market Research Report Information By Product Type (Botulinum Toxin, Dermal Fillers, Chemical Peels, Topical Skin Care Products, Skin Rejuvenation Devices) and By End-User (Hospitals and Clinics, Dermatology Clinics, Others) – Forecast to 2032

Table of Contents

1. REPORT PROLOGUE

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.2.1. Research Objective

2.2.2. Assumptions

2.2.3. Limitations

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Primary Research

3.3. Secondary Research

3.4. Market Size Estimation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.3. Restraints

4.4. Opportunities

5. MARKET FACTOR ANALYSIS

5.1. Porter’s Five Forces Analysis

5.1.1. Bargaining Power of Suppliers

5.1.2. Bargaining Power of Buyers

5.1.3. Threat of New Entrants

5.1.4. Threat of Substitutes

5.1.5. Intensity of Rivalry

5.2. Value Chain Analysis 

6. GLOBAL FACIAL REJUVENATION MARKET, BY PRODUCT TYPE

6.1. Overview

6.2. Botulinum Toxin

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3. Dermal Fillers

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.1. Hyaluronic Acid

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.2. Polymers & Particles

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.3. Calcium Hydroxyapatite

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.3.4. Collagen

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.4. Chemical Peels

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.5. Topical Skin Care Products

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6. Skin Rejuvenation Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.1. Intense Pulsed Light

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.2. Microdermabrasion

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.3. Laser-based Devices

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

6.6.4. Ultrasound

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7. GLOBAL FACIAL REJUVENATION MARKET, BY END USER

7.1. Overview

7.2. Hospitals and Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.3. Dermatology Clinics

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

7.4. Others

Market Estimates & Forecast, by Region, 2020-2027

Market Estimates & Forecast, by Country, 2020-2027

8. GLOBAL FACIAL REJUVENATION MARKET, BY REGION

8.1. Overview

8.2. Americas

8.2.1. North America

8.2.1.1. US

8.2.1.2. Canada

8.2.2. Latin America

8.3. Europe

8.3.1. Western Europe

8.3.1.1. Germany

8.3.1.2. France

8.3.1.3. Italy

8.3.1.4. Spain

8.3.1.5. UK

8.3.1.6. Rest of Western Europe

8.3.2. Eastern Europe

8.4. Asia-Pacific

8.4.1. Japan

8.4.2. China

8.4.3. India

8.4.4. Australia

8.4.5. South Korea

8.4.6. Rest of Asia-Pacific

8.5. Middle East & Africa

8.5.1. Middle East

8.5.2. Africa

9. COMPANY LANDSCAPE

9.1. Overview

9.2. Competitive Analysis

9.3. Market Share Analysis

9.4. Major Growth Strategy in the Global Facial Rejuvenation Market

9.5. Competitive Benchmarking

9.6. Leading Players in terms of Number of Developments in the Global Facial Rejuvenation Market

9.7. Key developments and Growth Strategies

9.7.1. New Product Launch/Service Deployment

9.7.2. Merger & acquisitions

9.7.3. Joint Ventures

9.8. Major Players Financial Matrix & Market Ratio

9.8.1. Sales & Operating Income 2018

9.8.2. Major Players R&D Expenditure 2018

9.9. Major Players Capital Market Ratio

10. COMPANY PROFILES

10.1. Allergan

10.1.1. Company Overview

10.1.2. Product Overview

10.1.3. Financial Overview

10.1.4. Key Developments

10.1.5. SWOT Analysis

10.1.6. Key Strategies

10.2. Merz Pharma

10.2.1. Company Overview

10.2.2. Product Overview

10.2.3. Financial Overview

10.2.4. Key Developments

10.2.5. SWOT Analysis

10.2.6. Key Strategies

10.3. Galderma

10.3.1. Company Overview

10.3.2. Product Overview

10.3.3. Financial Overview

10.3.4. Key Developments

10.3.5. SWOT Analysis

10.3.6. Key Strategies

10.4. Lumenis

10.4.1. Company Overview

10.4.2. Product Overview

10.4.3. Financial Overview

10.4.4. Key Developments

10.4.5. SWOT Analysis

10.4.6. Key Strategies

10.5. Revance

10.5.1. Company Overview

10.5.2. Product Overview

10.5.3. Financial Overview

10.5.4. Key Developments

10.5.5. SWOT Analysis

10.5.6. Key Strategies

10.6. Contura Ltd

10.6.1. Company Overview

10.6.2. Product Overview

10.6.3. Financial Overview

10.6.4. Key Developments

10.6.5. SWOT Analysis

10.6.6. Key Strategies

10.7. Anika Therapeutics, Inc.

10.7.1. Company Overview

10.7.2. Product Overview

10.7.3. Financial Overview

10.7.4. Key Developments

10.7.5. SWOT Analysis

10.7.6. Key Strategies

10.8. Fibrocell Science, Inc.

10.8.1. Company Overview

10.8.2. Product Overview

10.8.3. Financial Overview

10.8.4. Key Developments

10.8.5. SWOT Analysis

10.8.6. Key Strategies

10.9. Cynosure, A Hologic Company

10.9.1. Company Overview

10.9.2. Product Overview

10.9.3. Financial Overview

10.9.4. Key Developments

10.9.5. SWOT Analysis

10.9.6. Key Strategies

10.10. Daewoong Co. Ltd

10.10.1. Company Overview

10.10.2. Product Overview

10.10.3. Financial Overview

10.10.4. Key Developments

10.10.5. SWOT Analysis

10.10.6. Key Strategies

10.11. Sinclair Pharma

10.11.1. Company Overview

10.11.2. Product Overview

10.11.3. Financial Overview

10.11.4. Key Developments

10.11.5. SWOT Analysis

10.11.6. Key Strategies

10.12. Teoxane Laboratories

10.12.1. Company Overview

10.12.2. Product Overview

10.12.3. Financial Overview

10.12.4. Key Developments

10.12.5. SWOT Analysis

10.12.6. Key Strategies

10.13. Suneva Medical

10.13.1. Company Overview

10.13.2. Product Overview

10.13.3. Financial Overview

10.13.4. Key Developments

10.13.5. SWOT Analysis

10.13.6. Key Strategies

10.14. Solta Medical, a Subsidiary of Bausch Health Companies

10.14.1. Company Overview

10.14.2. Product Overview

10.14.3. Financial Overview

10.14.4. Key Developments

10.14.5. SWOT Analysis

10.14.6. Key Strategies

10.15. SciVision Biotech, Inc.

10.15.1. Company Overview

10.15.2. Product Overview

10.15.3. Financial Overview

10.15.4. Key Developments

10.15.5. SWOT Analysis

10.15.6. Key Strategies

10.16. Others

11. APPENDIX

11.1. References

11.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

• In section 10, major 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Product Portfolio, Business Strategies, and Recent Developments parameters.

• Please note: The financial details of the company cannot be provided if the information is not available in the public domain and or from reliable sources. 

LIST OF TABLES

TABLE 1 GLOBAL FACIAL REJUVENATION MARKET SYNOPSIS, 2020-2027

TABLE 2 GLOBAL FACIAL REJUVENATION MARKET ESTIMATES & FORECAST, 2020-2027 (USD MILLION)

TABLE 3 GLOBAL FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 4 GLOBAL FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 5 GLOBAL FACIAL REJUVENATION MARKET, BY REGION, 2020-2027 (USD MILLION)

TABLE 6 NORTH AMERICA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 7 NORTH AMERICA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 8 US: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 9 US: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 10 CANADA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 11 CANADA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 12 LATIN AMERICA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 13 LATIN AMERICA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 14 EUROPE: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 15 EUROPE: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 16 WESTERN EUROPE: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 17 WESTERN EUROPE: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 18 EASTERN EUROPE: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 19 EASTERN EUROPE: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 20 ASIA-PACIFIC: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 21 ASIA-PACIFIC: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

TABLE 22 MIDDLE EAST & AFRICA: FACIAL REJUVENATION MARKET, BY PRODUCT TYPE, 2020-2027 (USD MILLION)

TABLE 23 MIDDLE EAST & AFRICA: FACIAL REJUVENATION MARKET, BY END USER, 2020-2027 (USD MILLION)

LIST OF FIGURES

FIGURE 1 RESEARCH PROCESS

FIGURE 2 MARKET STRUCTURE FOR THE GLOBAL FACIAL REJUVENATION MARKET

FIGURE 3 MARKET DYNAMICS FOR THE GLOBAL FACIAL REJUVENATION MARKET

FIGURE 4 GLOBAL FACIAL REJUVENATION MARKET SHARE, BY PRODUCT TYPE, 2020(%)

FIGURE 5 GLOBAL FACIAL REJUVENATION MARKET SHARE, BY END USER, 2020(%)

FIGURE 6 GLOBAL FACIAL REJUVENATION MARKET SHARE, BY REGION, 2020(%)

FIGURE 7 AMERICAS: FACIAL REJUVENATION MARKET SHARE BY REGION, 2020(%)

FIGURE 7 NORTH AMERICA: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 8 EUROPE: FACIAL REJUVENATION MARKET SHARE, BY REGION, 2020(%)

FIGURE 9 WESTERN EUROPE: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 10 ASIA-PACIFIC: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 11 MIDDLE EAST & AFRICA: FACIAL REJUVENATION MARKET SHARE, BY COUNTRY, 2020(%)

FIGURE 12 GLOBAL FACIAL REJUVENATION MARKET: COMPANY SHARE ANALYSIS, 2020(%)

FIGURE 13 ALLERGAN.: KEY FINANCIALS

FIGURE 14 ALLERGAN: SEGMENTAL REVENUE

FIGURE 15 ALLERGAN: REGIONAL REVENUE

FIGURE 16 MERZ PHARMA: KEY FINANCIALS

FIGURE 17 MERZ PHARMA: SEGMENTAL REVENUE

FIGURE 18 MERZ PHARMA: REGIONAL REVENUE

FIGURE 19 GALDERMA: KEY FINANCIALS

FIGURE 20 GALDERMA: SEGMENTAL REVENUE

FIGURE 21 GALDERMA: REGIONAL REVENUE

FIGURE 22 LUMENIS: KEY FINANCIALS

FIGURE 23 LUMENIS: SEGMENTAL REVENUE

FIGURE 24 LUMENIS: REGIONAL REVENUE

FIGURE 25 REVANCE: KEY FINANCIALS

FIGURE 26 REVANCE: SEGMENTAL REVENUE

FIGURE 27 DEPLOYMENT: REGIONAL REVENUE

FIGURE 28 CONTURA LTD: KEY FINANCIALS

FIGURE 29 CONTURA LTD: SEGMENTAL REVENUE

FIGURE 30 CONTURA LTD: REGIONAL REVENUE

FIGURE 31 ANIKA THERAPEUTICS, INC.: KEY FINANCIALS

FIGURE 32 ANIKA THERAPEUTICS, INC.: SEGMENTAL REVENUE

FIGURE 33 ANIKA THERAPEUTICS, INC.: REGIONAL REVENUE

FIGURE 34 FIBROCELL SCIENCE, INC.: KEY FINANCIALS

FIGURE 35 FIBROCELL SCIENCE, INC.: SEGMENTAL REVENUE

FIGURE 36 FIBROCELL SCIENCE, INC.: REGIONAL REVENUE

FIGURE 37 CYNOSURE, A HOLOGIC COMPANY: KEY FINANCIALS

FIGURE 38 CYNOSURE, A HOLOGIC COMPANY: SEGMENTAL REVENUE

FIGURE 39 CYNOSURE, A HOLOGIC COMPANY: REGIONAL REVENUE

FIGURE 40 DAEWOONG CO. LTD: KEY FINANCIALS

FIGURE 41 DAEWOONG CO. LTD: SEGMENTAL REVENUE

FIGURE 42 DAEWOONG CO. LTD: REGIONAL REVENUE

FIGURE 43 SINCLAIR PHARMA: KEY FINANCIALS

FIGURE 44 SINCLAIR PHARMA: SEGMENTAL REVENUE

FIGURE 45 SINCLAIR PHARMA: REGIONAL REVENUE

FIGURE 46 TEOXANE LABORATORIES: KEY FINANCIALS

FIGURE 47 TEOXANE LABORATORIES: SEGMENTAL REVENUE

FIGURE 48 TEOXANE LABORATORIES: REGIONAL REVENUE

FIGURE 49 SUNEVA MEDICAL: KEY FINANCIALS

FIGURE 50 SUNEVA MEDICAL: SEGMENTAL REVENUE

FIGURE 51 SUNEVA MEDICAL: REGIONAL REVENUE

FIGURE 52 SOLTA MEDICAL, A SUBSIDIARY OF BAUSCH HEALTH COMPANIES: KEY FINANCIALS

FIGURE 53 SOLTA MEDICAL, A SUBSIDIARY OF BAUSCH HEALTH COMPANIES: SEGMENTAL REVENUE

FIGURE 54 SOLTA MEDICAL, A SUBSIDIARY OF BAUSCH HEALTH COMPANIES: REGIONAL REVENUE

FIGURE 55 SCIVISION BIOTECH INC.: KEY FINANCIALS

FIGURE 56 SCIVISION BIOTECH INC.: SEGMENTAL REVENUE

FIGURE 57 SCIVISION BIOTECH INC.: REGIONAL REVENUE